Risk for stroke and myocardial infarction with abiraterone versus enzalutamide in metastatic prostate cancer patients
Author:
Funder
Baylor College of Medicine
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference34 articles.
1. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion;Harris;Nat Clin Pract Urol,2009
2. Cardiovascular toxicities of systemic treatments of prostate cancer;Veccia;Nat Rev Urol,2017
3. Cardiovascular effects of androgen deprivation therapy in prostate cancer: contemporary meta-analyses;Hu;Arterioscler Thromb Vasc Biol,2020
4. Development of a second-generation antiandrogen for treatment of advanced prostate cancer;Tran;Science,2009
5. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven;Attard;J Clin Oncol,2008
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Assessment of Cardiovascular Events Caused by New-Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan;Oncology;2024-08-14
2. Prevalence and outcomes of atrial fibrillation in patients suffering prostate cancer: a national analysis in the United States;Frontiers in Cardiovascular Medicine;2024-04-04
3. Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology;Frontiers in Oncology;2024-01-31
4. Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study;Prostate Cancer and Prostatic Diseases;2023-12-05
5. Androgen deprivation therapy and cardiovascular morbidity in prostate cancer: a narrative review;Die Urologie;2023-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3